About
Graviton Bioscience develops novel selective ROCK2 inhibitors for the treatment of fibrotic, autoimmune, and central nervous system diseases by restoring homeostasis through multiple molecular pathways.
Explore Graviton Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.